Society Logo
ME/CFS Australia Ltd
Please click here to donate ME/CFS Australia (SA) Inc
 
 
Facebook
 
ME/CFS AUSTRALIA (SA) INC

Registered Charity 3104

Email:
sacfs@sacfs.asn.au

Mailing address:
PO Box 322,
Modbury North,
South Australia 5092

Office:
Suite 506,
North Terrace House,
19 North Terrace,
Hackney, SA, 5069


Phone:
1300 128 339

Office Hours:
Wednesdays, 11am-3pm

ME/CFS Australia (SA) Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.

Disclaimer

ME/CFS Australia (SA) Inc aims to keep members informed of various research projects, diets, medications, therapies, news items, etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.

Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.

Become a Member
PDF Application Form (PDF, 242KB)
Why become a member?

Bone mass and vitamin D levels in women with Fibromyalgia

Tuesday 10 September 2013

 

From ProHealth:

 

SkeletonBone Mass and Vitamin D Levels in Women with Fibromyalgia

ProHealth.com • September 8, 2013

Bone mass and vitamin D levels in women with a diagnosis of fibromyalgia.

By F. Mateos, et al.

Abstract:

No differences in either bone mineral density or serum 25OHD levels have been found between 205 women with fibromyalgia (both pre- and postmenopausal) and their controls. However, a lack of the expected 25OHD summer rise was observed in patients.

INTRODUCTION: Contradictory data have been published regarding a possible association between fibromyalgia and osteoporosis or hypovitaminosis D. Most studies, however, have been performed in small size samples and have excluded postmenopausal women. We decided to study this association in a larger sample of fibromyalgia patients including both pre- and postmenopausal women.

METHODS: Two hundred five patients were recruited from a clinic specializing in fibromyalgia and 205 healthy controls were enrolled from the census of a Primary Care Center. Controls were matched with patients by age and the time of the year they were included in the study. Bone mineral density (BMD) was measured by DXA. Serum 25OHD, iPTH, P1NP, and CTX were also determined.

RESULTS:

  • BMD was similar in both groups (lumbar spine, 0.971 ± 0.146 g/cm2 in patients and 0.970 ± 0.132 g/cm2 in controls; femoral neck, 0.780 ± 0.122 g/cm2 and 0.785 ± 0.117 g/cm2, respectively).

  • 25OHD levels were also similar: 23.0 ± 9.5 ng/ml and 24.1 ± 9.6 ng/ml.

  • However, while controls showed the usual summer rise in 25OHD, fibromyalgia patients did not.

  • PTH did not show seasonal changes, but on average was higher in patients (51 pg/ml vs. 48 pg/ml; p = 0.034).

  • P1NP or CTX were similar in both groups.

CONCLUSIONS: No differences in BMD were found between patients and controls. As for 25OHD, a lack of its expected summer rise was observed. It is doubtful whether this has any homeostatic consequence. We consider that the association reported in other studies is merely circumstantial, and not due to the intrinsic characteristics of these disorders.

Source: Osteoporosis International, September 6, 2013. By F. Mateos, C. Valero, J. M. Olmos, B. Casanueva, J. Castillo, J. Martínez, J. L. Hernández and J. González Macías. Department of Internal Medicine, University Hospital Marqués de Valdecilla. University of Cantabria. RETICEF. IFIMAV, 39005, Santander, Spain.

 

The above originally appeared here.

 


Arrow right

More Fibromyalgia News

 


 

blog comments powered by Disqus
Previous Previous Page